Korean J Urol.
2001 Dec;42(12):1251-1257.
The Prognostic Value of Tumor Angiogenesis, Hepatocyte Growth Factor and c-met Expression in Renal Cell Carcinoma
- Affiliations
-
- 1Department of Urology, College of Medicine, Pusan National University, Busan, Korea. lsd@hyowon.pusan.ac.kr
Abstract
-
PURPOSE: The purpose of this study was to evaluate the prognostic significance of tumor angiogenesis and angiogenic factors such as hepatocyte growth factor (HGF) and c-met in renal cell carcinoma.
MATERIALS AND METHODS
Immunohistochemical staining on HGF, c-met expression and angiogenesis was performed in 35 renal cell carcinoma tissues and 18 benign renal tissues. HGF and c-met were identified with specific corresponding antibodies. Cases were considered positive when HGF and c-met expression were seen in more than one third of cells. To evaluate the angiogenesis, the microvessels were determined by anti-CD31 immunohistochemistry. We compaired HGF, c-met and microvessel count with clinicopathologic characteristics such as stage, nuclear grade and histology in renal cell carcinoma.
RESULTS
Among 35 patients with renal cell carcinoma, 16 patients (45.7%) showed positive stain for HGF and c-met. HGF, c-met overexpression and microvessel count were significantly correlated with tumor stage and nuclear grade of renal cell carcinoma (p<0.05), but not correlated with cell type of renal cell carcinoma.
CONCLUSIONS
This results suggested that both HGF and c-met overexpression and angiogenesis measured by microvessels count could be significant prognostic indicators of renal cell carcinoma.